Latest

Research highlights “strikingly low” use of public defibrillators in cardiac arrest

6th June 2023

EU ministers approve changes to MDR transition timetable

7th March 2023

Vascade vascular and venous closure devices gain CE mark

13th September 2022

“Worrisome” rise in cardiovascular disease predicted out to 2060

4th August 2022

Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care

1st June 2022

cxvascular

Women underrepresented in cardiovascular clinical trial leadership positions

28th February 2022

ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease

19th November 2021

Almost one in 200 patients die early after AF ablation in...

29th October 2019

Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”

30th May 2023

HRS 2023: BIO-LIBRA study offers insights into device treatment of non-ischaemic...

26th May 2023

Two decades of development in AF treatment and education

27th September 2022

New data underpin drive towards earlier AF ablation strategies

23rd February 2022

Q-FFICIENCY trial shows promise for temperature-controlled ablation

1st February 2022

Pedro Brugada

27th November 2019

Write to us
Editorial: Will Date [email protected]
Advertising: Melanie Stevenson [email protected]

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: [email protected]

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: [email protected]

Terms and Conditions | Privacy Policy